Cost-effectiveness of a synchronized care clinic for cardiometabolic therapies

Patients with type 2 diabetes are at greater risk for cardiovascular disease, including stroke or heart failure. Newer medications can improve cardiometabolic health for patients with diabetes. But many clinicians are not yet comfortable prescribing these guideline-directed medications, and other clinicians are only comfortable after patients see several specialists. As a result, many patients do not receive guideline-directed medications, while others face long delays in beginning therapies. At the McGill University Health Centre, an innovative quickly and safely initiate guideline-directed therapies. In this new model, patients see three specialists at each appointment to efficiently adjust other medications and ensure safe initiation. In this project, we will use a simulation model to estimates outcomes for diabetes patients with and without guidelinedirected therapies. Using the model, we will estimate the clinical benefit and cost-effectiveness of this synchronized care model for patients with type 2 diabetes.

Faculty Supervisor:

W. Alton Russell

Student:

Partner:

McGill University Health Centre Foundation;McGill University Health Centre

Discipline:

Sociology

Sector:

Health and Related Sciences & Technology

University:

McGill University

Program: